ArticleFrontiers in genetics2022

Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib-a case report.

Yu-Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.